Drug-induced Liver Injury
📧 Sign up to get email alerts when something new happens for Drug-induced Liver Injury.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Drug-Induced Liver Injury (DILI) Network Retrospective
Duke University sponsors a clinical trial investigating drug-induced liver injury (DILI) through a retrospective network; the study is curre…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: DILIN - Prospective Study
A prospective DILI study run by the Drug-Induced Liver Injury Network (DILIN), sponsored by Duke University, is currently in recruitment.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Real World Study of Polyene Phosphatidylcholine Injection for the Prevention and Treatment of DILI in Patients With Malignant Hematological Diseases
A real-world study is evaluating polyene phosphatidylcholine injections for prevention and treatment of drug-induced liver injury in patient…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia [NA]
This clinical trial update notes a recruiting study evaluating glucocorticoids for acute drug-induced liver injury with hyperbilirubinemia.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: A Prognostic Model for Drug-induced Liver Injury in China
This clinical trial from Beijing Friendship Hospital is developing a prognostic model to predict drug-induced liver injury in China. The stu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , Karachi [Phase 1]
Phase 1 clinical trial at a tertiary care hospital comparing silymarin versus N-acetylcysteine for preventing or reducing drug-induced liver…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Drug-induced Liver Injury: Itching Study
A clinical trial from the University of Nottingham is currently recruiting to study drug-induced liver injury and pruritus (itching).
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: A Retrospective Study in Patients With Liver Injury After the Use of Novel Antineoplastic Agents
This retrospective study examines liver injury in patients treated with novel antineoplastic agents. The study is currently active but not r…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: A Prospective Cohort Study on Drug-induced Liver Injury in China（DILI-P）
A prospective cohort study in China (DILI-P) is currently recruiting to investigate drug-induced liver injury (DILI).
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure [NA]
Clinical trial investigating N-acetylcysteine for non-acetaminophen-induced acute liver failure; status is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study
An ongoing case-control study in China is screening genetic susceptibility genes for acetaminophen-induced drug-induced liver injury.
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver Disease [Phase 2, Phase 3]
A Phase 2/3 clinical trial update evaluating plasmapheresis for drug-induced liver injury in patients with chronic liver disease, currently …
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Prospective Comparative Validation Study of RUCAM and RECAM
This clinical trial update outlines a prospective comparative validation study of RUCAM and RECAM for drug-induced liver injury, currently r…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: Clinicopathological Features and Genetic Susceptibility Screening of Recurrent Drug-induced Liver Injury
The entry reports an ongoing clinical trial evaluating clinicopathological features and genetic susceptibility screening for recurrent drug-…
-
CLINICAL_TRIALS research · 2017-05-30Clinical Trial Update: Comparative Study of Circulating microRNA Changes in Patients With Liver Injury and Healthy Subjects
A clinical study comparing circulating microRNA changes between patients with liver injury (including drug-induced liver injury and liver fa…
-
CLINICAL_TRIALS research · 2017-03-28Clinical Trial Update: Surveillance for Early Liver Injuries Caused by Zhuanggu Guanjie Pill
This clinical trial update documents ongoing safety surveillance for early liver injuries potentially caused by Zhuanggu Guanjie Pill. The d…
-
CLINICAL_TRIALS research · 2017-03-27Clinical Trial Update: Surveillance for Early Liver Injuries Caused by Runzao Zhiyang Capsule.
A clinical trial update describing surveillance for early liver injuries potentially caused by Runzao Zhiyang Capsule.
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Clarify of Predictive Risk Factors of Chemotherapy-induced Liver Injury [Phase 4]
Phase 4 clinical trial update aiming to identify predictive risk factors for chemotherapy-induced drug-induced liver injury.
-
CLINICAL_TRIALS research · 2014-03-17Clinical Trial Update: NAT2 Genotyping in Re-challenge Protocol of INH Titration in Patients With Anti-TB Medications-induced Hepatitis [NA]
Clinical trial update examining NAT2 genotyping to guide a re-challenge protocol and isoniazid titration in patients who developed hepatitis…
-
CLINICAL_TRIALS research · 2014-02-19Clinical Trial Update: Establishment of Drug-induced Liver Injury Databases and Application of Circulating microRNA(miRNA)
This clinical trial update describes the establishment of drug-induced liver injury (DILI) databases and the investigation of circulating mi…
-
CLINICAL_TRIALS research · 2010-06-10Clinical Trial Update: Cholestatic Drug-induced Liver Injury [Phase 4]
Phase 4 clinical trial update on cholestatic drug-induced liver injury (toxic hepatitis) with unknown status, sponsored by Taipei Veterans G…